(Q39731338)

English

Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

health disparity

0 references

0 references

antimicrobial resistance

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

invasive disease

1 reference

based on heuristic

inferred from title

Thomas W Hennessy

1

object named as

Thomas W Hennessy

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

4

object named as

Dana L Bruden

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

9

object named as

Anne Schuchat

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Rosalyn J. Singleton

2

object named as

Rosalyn J Singleton

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

10

object named as

Jay C Butler

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

3

object named as

Lisa R Bulkow

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Alan J. Parkinson

8

object named as

Alan J Parkinson

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Debby A. Hurlburt

5

object named as

Debby A Hurlburt

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

Debra Parks

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Matthew Moore

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

0 references

publication date

12 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

48-49

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

5464-5473

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990--ethnic differences and opportunities for prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska, 1991-1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Impact of PCV7 on invasive pneumococcal disease among children younger than 5 years: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Incidence of invasive pneumococcal disease in children 3 to 36 months of age at a tertiary care pediatric center 2 years after licensure of the pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Streptococcus pneumoniae colonisation: the key to pneumococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: A controlled intervention trial in rural Alaska

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Effect of high-dose amoxicillin on the prevalence of penicillin-resistant Streptococcus pneumoniae in rural Alaska

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

A community intervention trial to promote judicious antibiotic use and reduce penicillin-resistant Streptococcus pneumoniae carriage in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Hepatitis A incidence and hepatitis a vaccination among American Indians and Alaska Natives, 1990-2001

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: the impact of persistent oropharyngeal carriage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.100

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.08.100

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39731338&oldid=2089190907"